SARS-CoV-2 Vaccination in Kidney Transplant Recipients: Should We Consider Intradermal Vaccination?

Wijtvliet, Veerle; Wissing, Karl Martin; Abramowicz, Daniel; Ledeganck, Kristien J

Wijtvliet, Veerle; Wissing, Karl Martin; Abramowicz, Daniel; Ledeganck, Kristien J.

Wijtvliet V; Department of Nephrology and Hypertension, Antwerp University Hospital, Edegem, Belgium veerle.wijtvliet@uantwerpen.be.
Wissing KM; Department of Nephrology, Universitair Ziekenhuis Brussel, Brussels, Belgium.
Abramowicz D; Department of Nephrology and Hypertension, Antwerp University Hospital, Edegem, Belgium.
Ledeganck KJ; Department of Nephrology and Hypertension, Antwerp University Hospital, Edegem, Belgium.

J Am Soc Nephrol ; 33(4): 869-870, 2022 04.

Article in English | MEDLINE | ID: covidwho-1686210

Subject(s)

COVID-19; Kidney Transplantation; Antibodies, Viral; COVID-19/prevention & control; COVID-19 Vaccines; Humans; SARS-CoV-2; Transplant Recipients; Vaccination

Keywords

COVID-19; COVID-19 vaccines; SARS-CoV-2; T lymphocytes; intradermal vaccination; kidney transplant recipients; third dose

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Kidney Transplantation / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: J Am Soc Nephrol Journal subject: Nephrology Year: 2022 Document Type: Article Affiliation country: Asn.2021121566

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google